Join us for our webinar on March 27 to discover the latest updates to the CAS STNext platform. Learn about new features, enhancements within specific databases, and more. Register today: https://ow.ly/IP6Y50VgSJQ
关于我们
At CAS, our passion is advancing scientific progress. As a leader in scientific information solutions, we curate, connect, and analyze the world’s published science to accelerate breakthroughs. CAS Solutions: Connecting research, patent, regulatory, and business professionals to the data and insights they need, our solutions speed progress through each phase of your pipeline. CAS Expertise: Our team of scientists and technologists embody a wealth of experience across disciplines and collectively speak more than 50 languages fueling our unique capabilities and insights. CAS Data: Our scientists curate, connect, and analyze the valuable data disclosed in scientific publications from around the world to build the CAS Content Collection?, covering over 150 years of discoveries. Our Team: Our team of over 1,000 scientists, technologists, and business professionals are passionate about advancing science and collectively speak more than 50 languages. We are proudly headquartered in Columbus, Ohio, with global offices in 45+ countries. Our History: Founded in 1907 as a volunteer effort to organize published chemistry research, CAS officially became a self-supporting division of the American Chemical Society in 1956.
- 网站
-
https://www.cas.org
美国化学文摘社的外部链接
- 所属行业
- IT 服务与咨询
- 规模
- 1,001-5,000 人
- 总部
- Columbus,Ohio
- 类型
- 非营利机构
- 创立
- 1907
- 领域
- chemistry-related information、database building、search and analysis technologies、Scientific Information、Advanced Analytics、Intellectual Property、knowledge management、life sciences、data management、data science、supply chain analysis、data governance、AI enablement、scientific research和patent searching
地点
-
主要
2540 Olentangy River Road
US,Ohio,Columbus,43202
美国化学文摘社员工
动态
-
Interest in lithium-ion #batteryrecycling is growing, but persistent challenges like energy usage and economic viability remain. Our most recent issue of the #CASInsights newsletter explores the latest trends that can revolutionize how we #recycle batteries, including insights from a CAS and Deloitte report.
-
The first #PPI inhibitor to treat leukemia was approved in 2020. Now, small molecules targeting PPIs are in Phase III clinical trials with more still in Phase II. Which cancers could be treated with these new drugs? Find out: https://ow.ly/kniK50UMAHC
-
Numerous CRISPR-based therapeutics are in the pre-clinical stage, and many are undergoing trials to validate their safety and efficiency for many treatments. Download our #CASInsights Report for a look inside the #patent and publication landscape: https://ow.ly/bSES50V0uaJ #CRISPR
-
We are looking forward to exhibiting at EBD Group BIO-EUROPE Spring 2025 in Milan! Visit our booth to discover how CAS can help you accelerate the innovation process. https://ow.ly/N77G50UL1If #CASConnect
-
With more #electricvehicles on the road, there are more lithium-ion batteries in circulation than ever before. But with the first generation of #EV batteries now reaching retirement, #batteryrecycling is key to handling this influx of waste: https://ow.ly/WssO50VeLS4
-
We'll be announcing our 2025 #CASFutureLeaders later this month. If you're selected for this year's program, how will you react? Learn more: https://ow.ly/2YpF50VfEBi
-
Join us on April 2 for a webinar with CAS Inventory Expert Service (IES) to learn how to obtain accurate and complete chemical substance identity information for your EPA PMN. Register today: https://ow.ly/UPMe50Vb2NC
-
Did you miss our latest CAS STNext coffee lecture on searching within full-text patent documents? Catch up on tips and tricks by watching the recording: https://ow.ly/uQbC50VeOWY